1 Journal of Biotechnology 103 (2003) 197/202 Short communication Comparison of hcmv immediate early and CaMV 35S promoters in both plant and human cells Josef Vlasák a, *, Michal Šmahel b, Adam Pavlík c, Daniela Pavingerová a, Jindřich Bříza a a Institute of Plant Molecular Biology, Academy of Sciences of the Czech Republic, CZ Branišovská 31, České Budějovice, Czech Republic b Institute of Hematology and Blood Transfusion, U Nemocnice 1, Praha 2, Czech Republic c Faculty of Biological Sciences, University of South Bohemia, Branišovská 31, České Budějovice, Czech Republic Received 6 January 2003; received in revised form 2 April 2003; accepted 8 May Abstract Cauliflower mosaic virus 35S promoter, widely used in transgenic crop plants, is known to be recognized in widely differing kinds of cells. Its activity in human cells may have impact on the risk assessment for the environmental release of genetically modified plants. In this study, transient expression of several constructs containing b-glucuronidase (GUS) gene driven by cauliflower mosaic virus 35S promoter or by immediate early promoter of human cytomegalovirus (pcmv) was tested in both potato leaf protoplasts and cultured human cells. The results showed very low but measurable activity of 35S promoter in human 293T-cells (0.01% of that revealed when using pcmv) and in 293 cells that do not produce SV40 T antigen this activity was even lower. On the other hand, in potato protoplasts, pcmv displayed nearly 1% activity seen with p35s. # 2003 Elsevier B.V. All rights reserved. Keywords: 35S promoter; hcmv promoter; Transient expression; Human cells; Potato protoplasts 1. Introduction * Corresponding author. Fax: / address: (J. Vlasák). The strong cauliflower mosaic virus (CaMV) 35S promoter (p35s) is used for the expression of transgenes in nearly all genetically modified crop plants. The promoter functions efficiently in all plants, as well as in green algae, yeast, and Escherichia coli (Assaad and Singer, 1990; Pobjecky et al., 1990). Hot discussions are under way in the scientific community about its possible activity in animal cells in association with safety concerns in genetically modified plants. Nevertheless, few relevant data have been published as yet: Ballas et al. (1989) have shown that p35s supported high level of reporter gene expression in mature Xenopus oocytes. The CaMV promoter has worked at least as well as the SV40 promoter in this system. In extracts of HeLa cell nuclei, p35s has been more efficient than the adenovirus 2 late promoter (Burke et al., 1990). Of course, these /03/$ - see front matter # 2003 Elsevier B.V. All rights reserved. doi: /s (03)00124-x
2 198 J. Vlasák et al. / Journal of Biotechnology 103 (2003) 197/202 systems provide very anomalous transcription conditions and for the typical animal cells the results are probably irrelevant. In this study, we compared the transient expression of bacterial b-glucuronidase (GUS) driven by p35s in both plant and human cells. To evaluate potency of p35s in human cells, p35s was exchanged with immediate early promoter of human cytomegalovirus (pcmv) in several constructs, and such cassettes were used as expression standards in human cells. pcmv is a very strong promoter that is often utilized in mammalian expression vectors (Boshart et al., 1985). Besides comparison of p35s and pcmv in human cells, the constructs with both promoters were also simultaneously tested in plant protoplasts. 2. Materials and methods 2.1. DNA constructs MonoGUS expression cassette containing CaMV 35S promoter and the first 15 codons of CaMV ORF I fused with the GUS gene (Bonneville et al., 1989) was used as standard in all experiments. Signal for transcription termination was derived from CaMV, too (Fig. 1). This expression cassette in puc plasmid was modified using procedures for the preparation of recombinant DNA plasmids described by Sambrook et al. (1989). Human cytomegalovirus promoter (pcmv) was excised from the vector pbsc (Šmahel et al., 2001) with enzymes Xba I and SalI, cloned into puc18 and recloned so that it was flanked by Kpn I sites. Kpn I fragment with pcmv was inserted into Kpn I site of Mono- GUS, 9-bp downstream of the transcription start of CaMV p35s, to obtain plasmid pcb0182 with both promoters in tandem and set of sites KpnI, SmaI, BamHI and XbaI ininverted orientation flanking the pcmv (Fig. 1). CaMV p35s promoter was then excised by digestion with BspMII site in front of p35s and partial digestion with XmaIin the polylinker and religation. Resulting plasmid pcb0199 has CaMV p35s replaced by pcmv in the MonoGUS cassette. For comparison, N-terminal ORF I codons of the ORF I/GUS fusion protein were excised from the pcb0182 together with pcmv using digestion with BamHI in the linkers and religation to obtain pcb1116- MonoGUS without ORF I fusion. Because of partial Bam HI digestion, pcb0192 was obtained, too, with the quasi-original Mono- GUS structure. The only difference is the palindromic set of sites KpnI, SmaI, BamHI, SmaI, Kpn I 9-bp downstream the CaMV p35s transcription start. Similarly, CaMV polyadenylation sequence was excised with the enzyme Sac I (pcb1161; Fig. 1). All plasmids were isolated by the cleared lysate method and purified by cesium chloride/ethidium bromide centrifugation (Sambrook et al., 1989). They were dissolved in water and adjusted to 2 mg DNA ml 1 before transfection Potato protoplast transfection and GUS activity assay Protoplasts were isolated from the leaf mesophyll cells of Solanum tuberosum L. cv. Bintje according to Bříza and Machová (1991). 0.5/10 6 of freshly prepared protoplasts in 1 ml SW 11 culture medium (Bříza and Machová, 1991) were PEG transfected (Negrutiu et al., 1987) with 50 mg of puc plasmid containing GUS expression cassette. Protoplasts were incubated for 24 h, collected, and lysed in 50 ml of GUS buffer (Jefferson, 1987). GUS activity as well as the protein content were measured in 10 ml of homogenate; the typical protein content was 0.5 /1.2 mg ml 1. GUS activity was assayed with the 4- methylumbelliferyl-b-d-glucuronide (MUG) fluorescent substrate according to Jefferson (1987) and proteins were determined according to Bradford (1976) Human cell transfection and GUS activity assay 293 human embryonal kidney cells (Graham et al., 1977) or 293T-cells derived from 293 cells by transduction with the gene coding for simian virus 40 (SV40) large T antigen (DuBridge et al., 1987) were used.
3 J. Vlasák et al. / Journal of Biotechnology 103 (2003) 197/ Fig. 1. Structure of the expression cassettes in puc plasmids used for transfection. The bars represent segments of DNA that have been inserted into plasmid vectors. The same symbols are used as in Table 1. Only relevant restriction sites are shown. 0.7/10 6 of cells were seeded into 6-cm plates and transfected on the next day by modified calcium phosphate precipitation in HEPES-buffered saline solution (Kingston et al., 1997) with 6 mg of plasmids. Cells were incubated for 48 h, collected, and lysed in 200 ml of GUS buffer. GUS
4 200 J. Vlasák et al. / Journal of Biotechnology 103 (2003) 197/202 activity and protein concentration were measured as described for potato protoplasts. The typical protein content was 0.7/1.3 mg ml Results The results of GUS assays are summarized in Table 1. CaMV p35s promoter conferred very low expression in human 293T-cells in all cassettes studied (about 10,000 times lower than pcmv). On the other hand, pcmv showed surprisingly high activity in plant cells*/only about 100 times lower than the extremely strong plant p35s promoter. To the best of our knowledge, this observation has not yet been reported. When pcmv was inserted between p35s and I/ GUS gene (pcb0182), the GUS activity was substantially reduced in plant protoplasts. In 293T-cells, the expression of GUS from the tandem of p35s-pcmv promoters was comparable with that from pcmv only. N-terminal ORF I codons from the natural CaMV 35S mrna provide the optimal sequence for the eucaryotic translation start resulting in very high level of GUS expression in plant protoplasts (Bonneville et al., 1989) as well as in transgenic plants (Vlasák and Toušová, 1997). Deletion of the ORF I codons (pcb 1116) that reveals the original start codon of bacterial b-glucuronidase as the first ATG on the mrna causes drop of GUS activity in potato protoplasts to about 6% and the deletion of the CaMV transcription termination signal (pcb 1161) had even stronger effect. All these effects could also be seen in human cells, but a more exact evaluation was impossible because of low GUS activity. The results are in accordance with the published data describing eucaryotic translation start consensus sequence (Kozak, 1981) and mrna stability improvement by appropriate polyadenylation sequence. Nevertheless, the most pronounced drop of activity occurred when using structure where symmetrical (palindromic) linker KpnI/SmaI/BamHI/SmaI/KpnI was obtained after several cloning steps 9-bp downstream the mrna cap (pcb0192). This hairpin structure probably impairs ribosome landing on mrna substantially. After excision of the palindrom with enzyme Kpn I, we obtained plasmid pcb1117 with the same structure and activity as MonoGUS (not shown in Table 1). Human 293T-cells express T antigen of SV40 that has been shown to transactivate some viral and cellular promoters (Rice and Cole, 1993). To assess the influence of T antigen on the activity of p35s and pcmv promoters, GUS activity was also determined in 293 cells lacking T antigen. In accordance with published data (Moens et al., Table 1 Expression of GUS in potato and human cells driven by CaMV 35S or hcmv promoters Expression cassette Structure Relative activity (%) Potato protoplasts 293T-cells MonoGUS p35s-i/gus! /0.002 pcb 0199 pcmv-i/gus! 0.619/ pcb 0182 p35s-pcmv-i/gus! 0.739/ /4 pcb 1116 p35s-gus! 6.59/ /0.004 pcb 1161 p35s-i/gus 5.09/ /0.001 pcb 0192 p35s-mcs-i/gus! 1.509/ /0.001 Each value represents the mean of three repeated experiments9/standard deviation. MonoGUS cassette was always used as a standard. Its absolute activity varied in potato protoplasts in the range 210/920 pmol MUG min 1 mg protein 1 and the actual value was used as 100% in each experiment. In human cells, the range for MonoGUS was 0.14/0.33 pmol MUG min 1 mg protein 1. pcb0199 with the same fusion driven by hcmv promoter was used as a 100% standard in experiments with human cells. The activities determined varied in the range 1100/2420 pmol MUG min 1 mg protein 1. The background increase of fluorescence represented maximally 0.1 pmol MUG min 1. Symbols: p35s: CaMV 35S promoter; pcmv: hcmv immediate early promoter;!: CaMV transcription termination signal, I: first 15 codons of CaMV ORF I; MCS: multiple cloning site-sequence with restriction sites KpnI/SmaI /BamHI/SmaI /KpnI.
5 J. Vlasák et al. / Journal of Biotechnology 103 (2003) 197/ ), these experiments demonstrated profound effect of T antigen on the expression driven by pcmv (GUS activity was 10/20 times lower in 293 cells*/data not shown). Activity of p35s was reduced similarly in the absence of T antigen. 4. Discussion GUS expression driven by p35s promoter could be readily detected in 293T human cells, although in a much lower extent than in plant protoplasts. Nevertheless, such direct comparison is of little value because of very different conditions for DNA transfection in different cell types. Comparison of CaMV 35S (plant) and hcmv (animal) promoters in each type of cells (Table 1) shows several thousand times lower activity of p35s in human cells. It indicates that the potential hazards associated with the use of p35s may not be so serious as it is sometimes maintained. Recent reports have suggested that because of a proposed recombination hotspot, the consumption of transgenic plants that contain the 35S promoter may result in inappropriate overexpression of genes leading to cancer in humans, or that recombination may lead to the reactivation of dormant viruses or the creation of new viruses (Ho et al., 1999). It is questionable whether relatively low transcription activity of CaMV 35S promoter can induce such hazardous events in mammalian cells. On the other hand, only about 100-fold lower expression of widely used animal pcmv in plant cells is surprising. Expression levels this high have not even been reported with some genuine plant promoters. This fact should be kept in mind in the course of design and use of eucaryotic expression vectors. Acknowledgements We are grateful to Dr. T. Hohn for the gift of the MonoGUS expression cassette used in this study. We would also like to thank Dr. Šárka Nemecková and Prof. V. Vonka for many helpful discussions and critical reading of the manuscript. This work was supported by the Grant Agency of the Czech Republic, Grant No. GA310/00/0381. References Assaad, F.F., Singer, E.R., Cauliflower mosaic virus p35s promoter activity in Escherichia coli. Mol. Gen. Genet. 223, 517/520. Ballas, N., Broido, S., Soreq, H., Loyter, A., Efficient functioning of plant promoters and poly(a) sites in Xenopus oocytes. Nucl. Acids Res. 17, 7891/7903. Bonneville, J.M., Sanfaçon, H., Fütterer, J., Hohn, T., Posttranscriptional trans-activation in cauliflower mosaic virus. Cell 59, 1135/1143. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., Schaffner, W., A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521/530. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248/ 254. Bříza, J., Machová, I., Regeneration of plants from leaf mesophyll protoplasts of the tetraploid potato cultivars Xenia and Bintje. Biol. Plant. 33, 225/233. Burke, C., Yu, X.B., Marchitelli, L., Davis, E.A., Ackerman, S., Transcription factor IIA of wheat and human function similarly with plant and animal viral promoters. Nucl. Acids Res. 18, 3611/3620. DuBridge, R.B., Tang, P., Hsia, H.C., Leong, P.M., Miller, J.H., Calos, M.P., Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379/387. Graham, F.L., Smiley, J., Russell, W.C., Nairn, R., Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59/74. Ho, M.-W., Ryan, A., Cummins, J., Cauliflower mosaic viral promoter*/a recipe for disaster? Microb. Ecol. Health Dis. 11, 194/197. Jefferson, R.A., Assaying chimeric genes in plants: the GUS gene fusion system. Plant. Mol. Biol. Rep. 5, 387/405. Kingston, R.E., Chen, C.A., Okayama, H., Rose, J.K., Calcium phosphate transfection. In: Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K. (Eds.), Current Protocols in Molecular Biology. Wiley, New York, pp / Kozak, M., Possible role of flanking nucleotides in recognition of the AUG initiator codon by eucaryotic ribosomes. Nucl. Acids Res. 9, 5233/5252. Moens, U., Van Ghelue, M., Kristoffersen, A.K., Johansen, B., Rekvig, O.P., Degre, M., Rollag, H., Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoter. Virus Genes 23, 215/226.
6 202 J. Vlasák et al. / Journal of Biotechnology 103 (2003) 197/202 Negrutiu, I., Shillito, R., Potrykus, I., Biasini, G., Sala, F., Hybrid genes in the analysis of transformation conditions. 1. Setting up a simple method for direct genetransfer in plant-protoplasts. Plant. Mol. Biol. 8, 363/373. Pobjecky, N., Rosenberg, G.H., Dinter-Gottlieb, G., Käufer, N.F., Expression of the b-glucuronidase gene under the control of the CaMV 35S promoter in Schizosacharomyces pombe. Mol. Gen. Genet. 220, 314/316. Rice, P.W., Cole, C.N., Efficient transcriptional activation of many simple modular promoters by simian virus 40 large T antigen. J. Virol. 67, 6689/6697. Sambrook, K., Fritsch, E.F., Maniatis, T., Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Press, New York, USA..Šmahel, M., Šíma, P., Ludvíková, V., Vonka, V., Modified HPV16 E7 genes as DNA vaccine against E7- containing oncogenic cells. Virology 281, 231/238. Vlasák, J., Toušová, M., Gene dosis effects in plants transgenic for monocistronic and activated dicistronic GUS constructs. In: Book of Abstracts from 2nd Symp. Ser. Recent Advances in Plant Biotechnology: Molecular Biology for Agriculture, České Budějovice, August 25/29, UMBR AV ČR České Budĕjovice, p 159.
Chapter 9 Biotechnology and Recombinant DNA Biotechnology and Recombinant DNA Q&A Interferons are species specific, so that interferons to be used in humans must be produced in human cells. Can you think
HCS604.03 Exercise 1 Dr. Jones Spring 2005 Recombinant DNA (Molecular Cloning) exercise: The purpose of this exercise is to learn techniques used to create recombinant DNA or clone genes. You will clone
RECOMBINANT DNA TECHNOLOGY By; Dr. Adeel Chaudhary 2 nd yr Molecular Genetics Medical Technology College of Applied Medical Sciences Recombinant DNA is a form of artificial DNA that is made through the
STOP Before using this product, please read the Limited Use License statement below: Important Limited Use License information for pdrive5lucia-rgfap The purchase of the pdrive5lucia-rgfap vector conveys
1. A recombinant DNA molecules is one that is a. produced through the process of crossing over that occurs in meiosis b. constructed from DNA from different sources c. constructed from novel combinations
Recombinant DNA and Biotechnology Chapter 18 Lecture Objectives What Is Recombinant DNA? How Are New Genes Inserted into Cells? What Sources of DNA Are Used in Cloning? What Other Tools Are Used to Study
Genetics 10201232 Faculty of Agriculture and Veterinary Medicine Instructor: Dr. Jihad Abdallah Topic 15:Recombinant DNA Technology 1 Recombinant DNA Technology Recombinant DNA Technology is the use of
pcdna 3.1(+) pcdna 3.1( ) Catalog nos. V790-20 and V795-20 Version K 10 November 2010 28-0104 User Manual ii Table of Contents Important Information...v Accessory Products...vi Methods... 1 Overview...1
Name: Class: Date: Genetic Technology Multiple Choice Identify the choice that best completes the statement or answers the question. 1. An application of using DNA technology to help environmental scientists
1 2 Restriction enzymes were first discovered with the observation that a. DNA is restricted to the nucleus. b. phage DNA is destroyed in a host cell. c. foreign DNA is kept out of a cell. d. foreign DNA
Protein Expression A Practical Approach S. J. HIGGIN S B. D. HAMES List of contributors Abbreviations xv Xvi i 1. Protein expression in mammalian cell s Marlies Otter-Nilsson and Tommy Nilsso n 1. Introduction
Lecture 36: Basics of DNA Cloning-II Note: Before starting this lecture students should have completed Lecture 35 Sequential steps involved in DNA cloning using plasmid DNA as vector: Molecular cloning
Biochem 717 Gene Cloning Prof Amer Jamil Dept of Biochemistry University of Agriculture Faisalabad How to construct a recombinant DNA molecule? DNA isolation Cutting of DNA molecule with the help of restriction
Engineering of Yellow Mosaic Virus Resistance (YMVR) in Blackgram ID: Duration: Coordinator in Switzerland: PS1 1 April 2000 to 31 August 2004 Prof. Thomas Hohn University of Basel Botanisches Institut
Biotechnology Chapter 20: Biotechnology: DNA Technology & Genomics The BIG Questions How can we use our knowledge of DNA to: o Diagnose disease or defect? o Cure disease or defect? o Change/improve organisms?
Supplementary Figure 1. (A) MicroRNA 212 enhances IS from pancreatic β-cells. INS-1 832/3 β-cells were transfected with precursors for mirnas 212, 375, or negative control oligonucleotides. 48 hrs after
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University C H A P T E R 8 Recombinant DNA Technology The Role of Recombinant DNA Technology in Biotechnology Biotechnology
Molecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION Susan Carson Heather B. Miller D.Scott Witherow ELSEVIER AMSTERDAM BOSTON HEIDELBERG LONDON NEW YORK OXFORD PARIS SAN DIEGO SAN
Biotechnology and Recombinant DNA Recombinant DNA procedures - an overview Biotechnology: The use of microorganisms, cells, or cell components to make a product. Foods, antibiotics, vitamins, enzymes Recombinant
Integrated Protein Services Custom protein expression & purification Version DC04-0012 Expression strategy The first step in the recombinant protein generation process is to design an appropriate expression
Chapter 20. Biotechnology: DNA Technology & Genomics 2003-2004 The BIG Questions How can we use our knowledge of DNA to: diagnose disease or defect? cure disease or defect? change/improve organisms? What
USER GUIDE Fluorescein Isothiocyanate (FITC)- conjugated Antibodies Catalog Numbers R933-25, R953-25, R963-25 Document Part Number 25-0376 Publication Number MAN0000194 Revision 2.0 For Research Use Only.
Integrated Protein Services Custom protein expression & purification Last date of revision June 2015 Version DC04-0013 www.iba-lifesciences.com Expression strategy The first step in the recombinant protein
Recombinant DNA Technology Dates in the Development of Gene Cloning: 1965 - plasmids 1967 - ligase 1970 - restriction endonucleases 1972 - first experiments in gene splicing 1974 - worldwide moratorium
Development of M13 as a Single-stranded Cloning Vector: Insertion of the Tn3 Transposon into the Genome of M13 Dan S. Ray and Karin Kook Molecular Biology Institute and Department of Biology University
Bio 100 DNA Technology 1 Chapter 12 - DNA Technology Among bacteria, there are 3 mechanisms for transferring genes from one cell to another cell: transformation, transduction, and conjugation 1. Transformation
Page: 1 Molecular Cloning A glaring problem in most areas of biochemical research is obtaining sufficient amounts of the substance of interest. For example, a 10 L culture of E. coli grown to its maximum
Gene Cloning Technology Also known as: Genetic engineering or Genetic manipulation (GM) technology implies precision engineering being applied to DNA molecules Recombinant DNA technology - implies that
Home Page News Updates History of Plant Breeding What Are Transgenic Plants? How Do You Make A Transgenic Plant? Introduction to DNA Locating genes for plant traits Designing genes for insertion Transformation
i 1 INTRODUCTION 1.1 Human Hepatitis B virus (HBV) 1 1.1.1 Pathogenesis of Hepatitis B 1 1.1.2 Genome organization of HBV 3 1.1.3 Structure of HBV virion 5 1.1.4 HBV life cycle 5 1.1.5 Experimental models
MMG 301 Lec. 28 Genetic Engineering Basics Questions for Today: 1. How does one obtain a DNA fragment containing the desired gene using restriction enzymes? using the Polymerase Chain Reaction (PCR)? 2.
Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Primary Source for figures and content: Eastern Campus Tortora, G.J. Microbiology
pglo Bacterial Transformation Practical What is transformation? Genetic transformation literally means change caused by genes. It occurs when a cell takes up (takes inside) and expresses a new piece of
Chapter 9 Topics - Genetics - Flow of Genetics/Information - Regulation - Mutation - Recombination gene transfer Genetics Genome - the sum total of genetic information in a organism Genotype - the A's,
TABLE OF CONTENTS PART 1 THE BASIC PRINCIPLES OF GENE CLONING AND DNA ANALYSIS Chapter 1 Why Gene Cloning and DNA Analysis are Important 1.1 The early development of genetics 1.2 The advent of gene cloning
Lectures 26 and 27 recombinant DNA technology I. oal of genetics A. historically - easy to isolate total DNA - difficult to isolate individual gene B. recombinant DNA technology C. why get the gene? 1.
Pre/Post-quiz Assessment Study Biol. 462 Lab [Correct answer is italicized. Blue questions are in post-quiz only.] Students: to assess whether or not the laboratory of this course helps you learn concepts
Name Date Isolation and Electrophoresis of Plasmid DNA Prior to lab you should be able to: o Explain what cloning a gene accomplishes for a geneticist. o Describe what a plasmid is. o Describe the function
Biotechnology and reporter genes Here, a lentivirus is used to carry foreign DNA into chickens. A reporter gene (GFP)indicates that foreign DNA has been successfully transferred. Recombinant DNA continued
Chapter 5: Organization and Expression of Immunoglobulin Genes I. Genetic Model Compatible with Ig Structure A. Two models for Ab structure diversity 1. Germ-line theory: maintained that the genome contributed
CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA INTRODUCTION DNA : DNA is deoxyribose nucleic acid. It is made up of a base consisting of sugar, phosphate and one nitrogen base.the
laroslav Neliubov/ShutterStock, Inc. 1 Bacterial Transformation Introduction Microorganisms or microbes are divided into three groups: prokaryotes, eukaryotes, and viruses. Prokaryotes include bacteria,
European Medicines Agency July 1996 CPMP/ICH/139/95 ICH Topic Q 5 B Quality of Biotechnological Products: Analysis of the Expression Construct in Cell Lines Used for Production of r-dna Derived Protein
SUGAR BEET (Beta vulgaris L.) PROMOTERS FOR DIRECTED TISSUE- SPECIFIC ROOT TRANSCRIPTION Senthilkumar Padmanaban, Haiyan Li, David P. Puthoff and Ann C. Smigocki USDA-ARS Molecular Plant Pathology Laboratory,
pmod2-puro A plasmid containing a synthetic Puromycin resistance gene Catalog # pmod2-puro For research use only Version # 11H29-MM PrOduct information content: - 20 mg of lyophilized pmod2-puro plasmid
Protein Synthesis Protein synthesis is simply the "making of proteins." Although the term itself is easy to understand, the multiple steps that a cell in a plant or animal must go through are not. In order
SYNTHETIC BIOLOGY PRACTICAL Biological Databases and tools for handling DNA sequences BACKGROUND Your boss has asked you to express the gene meca in E. coli so that you can characterize the protein and
QuickClean 96-Well Plasmid Miniprep Kit L00237 Technical Manual No. TM 0231 Version 0712007 I Description.. 1 II Kit Contents.. 1 III Applications 2 IV Key Features.. 2 V Storage.. 2 VI Plasmid Miniprep
Gene Cloning Technology Also known as: Genetic engineering or Genetic manipulation (GM) technology implies precision engineering being applied to DNA molecules Recombinant DNA technology - implies that
Module 4B Biotechnology In this module, we will examine some of the techniques scientists have developed to study and manipulate the DNA of living organisms. Objective # 7 Explain what genetic recombination
Name Period The AP Biology exam has reached into this chapter for essay questions on a regular basis over the past 15 years. Student responses show that biotechnology is a difficult topic. This chapter
Genetic Engineering Genetically-modified animals Bovine Growth Hormone (BGH) Protein that increases milk production when injected How did scientists get bacteria to produce BGH? Goals: Be able to Describe
MODULE 2 Objective 2.1 Lesson E GFP Transformation Genetic Manipulations Course Advanced Biotechnology Unit DNA Technology Essential Question How is foreign DNA genes taken up by organisms and expressed?
restriction enzymes 350 Home Restriction Enzymes (endonucleases): molecular scissors that cut DNA Properties of widely used Type II restriction enzymes: recognize a single sequence of bases in dsdna, usually
OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation -Optimal strategies to a successful mirna research project Optimal strategies to a successful mirna research
UvA-DARE (Digital Academic Repository) Fitness landscapes of gene regulation in variable environments Poelwijk, F.J. Link to publication Citation for published version (APA): Poelwijk, F. J. (2008). Fitness
Transformation Making Change Happen Genetic Engineering Definition: The alteration of an organism s genetic, or hereditary, material to eliminate undesirable characteristics or to produce desirable new
Genetic Engineering of Plants Chem 210 3/22/00 What we ve learned so far... Genes can be cloned into vectors (such as plasmids). These vectors can be introduced into bacteria (such as E. coli). The foreign
PLO B6: Genetic Engineering is the direct manipulation of genes for practical purposes Genetic Engineering (cont d) Recombinant (r): from one species inserted into another species Usually use viruses &
page 1 of 7 MEF Starter Nucleofector Kit for Mouse Embryonic Fibroblasts (MEF) MEF display significant phenotypic variations which depend on the strain, the genetic background of the mice they are isolated
Log In Sign Up Biotechnology Test Test 15 Matching Questions Regenerate Test 1. Plasmid 2. PCR Process 3. humulin 4. pluripotent 5. polymerase chain reaction (PCR) a b Is much smaller than the human genome,
Biotechnology bio and technology The use of living organisms to solve problems or make useful products. Biotechnology has been practiced for the last 10,000 years. Selective breeding Use of microbes (bacteria
STUDIES ON SEED STORAGE PROTEINS OF SOME ECONOMICALLY MINOR PLANTS THESIS SUBMITTED FOR THE DEGREB OF DOCTOR OF PHILOSOPHY (SCIENCE) OF THE UNIVERSITY OF CALCUTTA 1996 NRISINHA DE, M.Sc DEPARTMENT OF BIOCHEMISTRY
MUTATION, DNA REPAIR AND CANCER 1 Mutation A heritable change in the genetic material Essential to the continuity of life Source of variation for natural selection New mutations are more likely to be harmful
Home Contacts Order Catalog Support Search Alphabetical Index Numerical Index Restriction Endonucleases Modifying Enzymes PCR Kits Markers Nucleic Acids Nucleotides & Oligonucleotides Media Transfection
Common Course Topics Biology 1406: Cell and Molecular Biology 1. Introduction to biology --the scientific study of organisms --properties of life --assumptions, methods and limitations of science --underlying
Cloning vectors E. coli Yeast Plants Insects Cloning vectors for E. coli The simplest cloning vectors are based on small bacterial plasmids Desirable properties: -Easy purification -High transformation
Bacterial Transformation and Plasmid Purification Chapter 5: Background History of Transformation and Plasmids Bacterial methods of DNA transfer Transformation: when bacteria take up DNA from their environment
1 So, what is biotechnology?? The use of living organisms to carry out defined chemical processes for industrial or commercial application. The office of Technology Assessment of the U.S. Congress defines
Bio 102 Practice Problems Recombinant DNA and Biotechnology Multiple choice: Unless otherwise directed, circle the one best answer: 1. Which of the following DNA sequences could be the recognition site
Recombinant DNA technology (genetic engineering) involves combining genes from different sources into new cells that can express the genes. Recombinant DNA technology has had-and will havemany important
Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue Application Guide... 2 I. Description... 2 II. Product Components... 2 III. Materials to be Supplied
DNA Scissors: Introduction to Restriction Enzymes Objectives At the end of this activity, students should be able to 1. Describe a typical restriction site as a 4- or 6-base- pair palindrome; 2. Describe
GenBank, Entrez, & FASTA Nucleotide Sequence Databases First generation GenBank is a representative example started as sort of a museum to preserve knowledge of a sequence from first discovery great repositories,
Unit 7 Study Guide Section 8.7: Mutations KEY CONCEPT Mutations are changes in DNA that may or may not affect phenotype. VOCABULARY mutation point mutation frameshift mutation mutagen MAIN IDEA: Some mutations
Your consent to our cookies if you continue to use this website.